MICHELLE JACOBSON: Open Payments
NPI 1467966473 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$682 in 46 payments from 15 companies in 2025. Trend: 2023 $613 · 2024 $382 · 2025 $682
Food & beverage: $645Education: $37
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $82 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 15 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| Amgen Inc. | 3 | $59 |
| Mallinckrodt Hospital Products Inc. | 2 | $51 |
| Calliditas Therapeutics US Inc. | 2 | $44 |
| Novo Nordisk Inc | 2 | $40 |
| Apellis Pharmaceuticals, Inc. | 2 | $37 |
Products named: LifeVest, Kerendia, LOKELMA, JYNARQUE, REPATHA, TERLIVAZ, TARPEYO, LEQVIO.
Industry payments across PA — which companies pay providers there.
